Skip to content

The study on the correlative factors of hemiplegic genu recurvatum and the mechanism of secondary knee joint injury

The study on the correlative factors of hemiplegic genu recurvatum and the mechanism of secondary knee joint injury

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039641
Enrollment
Unknown
Registered
2020-11-04
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genu recurvatum after stroke

Interventions

no recurvatum:Nil
mild revurvatum:Nil
severe recurvatum:Nil

Sponsors

Beijing Rehabilitation Medical College Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with hemiplegia of one side of the limb in the first 6 months; 2. The subjects who can walk at least 10 meters independently and safely had at least 3 months walking time before entering the group, and the fac grade was III or above; 3. Patients with lower extremity Brunnstrom stage III or above; 4. Patients without previous knee injury; 5. Patients without nails, plates, drainage tubes, intrauterine devices and other metal products; 6. Patients with informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with nervous system diseases that affect walking ability, such as involuntary movement, Parkinson's disease, tremor, etc; 2. The patients with obvious cognitive impairment (Mini Mental State Examination < 24 points) and audio-visual comprehension disorder were unable to cooperate; 3. Patients with severe heart, lung, liver and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
3-D gait analysis;Isometric Muscle Strength Test;MRI;

Countries

China

Contacts

Public ContactGong Weijun

Beijing Rehabilitation Medical College Affiliated to Capital Medical University

gwj1971@163.com+86 13240473005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026